Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
Original Source Link
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Previous ArticleReagan Appointed Federal Judge Blocks Trump Executive Order Ending Birthright Citizenship
Next Article Queer Jams of the Week: Shygirl, Kesha and More